CTRI/2024/07/070001尚未招募Unknown
A comparison between efficacy of topical JAK inhibitors alone versus topical JAK inhibitor with phototherapy in vitiligo patients in a tertiary health care centre: An open labelled study - NI
Dr Sneha Ulhaskumar Arakeri0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients of vitiligo with = 2 depigmented patches (not on the mucosa) each =10% BSA
排除标准
- •Patients with mucosal lesions
研究者
相似试验
尚未招募
2 期
A CLINICAL TRIAL TO STUDY THE EFFECT OF TWO DRUGS JAK INHIBITORS (TOFACITINIB) AND NSAIDS ON PATIENTS WITH AXIAL SPONDYLOARTHROPATHIESCTRI/2024/04/066083Dr Nilotpal Saikia
尚未招募
不适用
Influence of JAK inhibitors on the disease-associated network of intestinal immune cells in ulcerative colitisUlcerative ColitisNL-OMON51787eids Universitair Medisch Centrum70
尚未招募
2 期
leech therapy in diabetic foot ulcerCTRI/2020/11/029286BLDEUS SHRI B M PATIL MEDICAL COLLEGE AND RESEARH CENTRE
进行中（未招募）
不适用
A Randomized Study of the JAK Inhibitor INCB018424 Tablets Compared to Best Available Therapy in Subjects with Primary Myelofibrosis (PMF), Post-Polycythemia Vera-Myelofibrosis (PPV-MF) or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) - COMFORT IIMedDRA version: 12.0Level: LLTClassification code 10028537Term: MyelofibrosisMyelofibrosisEUCTR2009-009858-24-ITIncyte Corporation150
Unknown
3 期
Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to MethotrexateRheumatoid ArthritisJAK InhibitorIL-6 InhibitorMusculoskeletal UltrasoundBiomarkerNCT05090410Atsushi Kawakami400